227 related articles for article (PubMed ID: 14557451)
1. A reappraisal of the utility of somatostatin receptor scintigraphy in patients with ectopic adrenocorticotropin Cushing's syndrome.
Tsagarakis S; Christoforaki M; Giannopoulou H; Rondogianni F; Housianakou I; Malagari C; Rontogianni D; Bellenis I; Thalassinos N
J Clin Endocrinol Metab; 2003 Oct; 88(10):4754-8. PubMed ID: 14557451
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of somatostatin receptor scintigraphy in patients with occult ectopic adrenocorticotropin syndrome.
Tabarin A; Valli N; Chanson P; Bachelot Y; Rohmer V; Bex-Bachellerie V; Catargi B; Roger P; Laurent F
J Clin Endocrinol Metab; 1999 Apr; 84(4):1193-202. PubMed ID: 10199752
[TBL] [Abstract][Full Text] [Related]
3. Successful use of 111In-pentetrotide scintigraphy for localizing ectopic adrenocorticotropin-producing bronchial carcinoid tumor in a patient with Cushing's syndrome.
Kishida K; Moriwaki M; Miyagawa J; Okita K; Kondo T; Itoh K; Umemura S; Kozawa J; Iwahashi H; Yoshizumi T; Imagawa A; Yamagata K; Maruyama T; Toyoshima H; Kurokawa E; Funahashi T; Matsuzawa Y
Intern Med; 2003 Oct; 42(10):996-1005. PubMed ID: 14606715
[TBL] [Abstract][Full Text] [Related]
4. [Cushing's syndrome secondary to bronchial carcinoid tumor: use of octreoScan in the location diagnosis].
Gómez Merino E; Navarro Martínez A; Solís del Pozo JE; Andrés Mompeán E; Requejo R
An Med Interna; 2003 Jan; 20(1):52. PubMed ID: 12666316
[No Abstract] [Full Text] [Related]
5. Use of radioguided surgery with [111In]-pentetreotide in the management of an ACTH-secreting bronchial carcinoid causing ectopic Cushing's syndrome.
Grossrubatscher E; Vignati F; Dalino P; Possa M; Belloni PA; Vanzulli A; Bramerio M; Marocchi A; Rossetti O; Zurleni F; Loli P
J Endocrinol Invest; 2005 Jan; 28(1):72-8. PubMed ID: 15816375
[TBL] [Abstract][Full Text] [Related]
6. 111In-octreotide scintigraphy in endocrine tumors. Preliminary data.
Cremonini N; Furno A; Sforza A; Chiarini V; Graziano E; Zampa G; Turba E
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):116-20. PubMed ID: 9002767
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of an ectopic adrenocorticotropic hormonesecreting bronchial carcinoid by somatostatin receptor scintigraphy.
Anaforoğlu I; Ersoy K; Aşık M; Karyağar S; Algün E
Clinics (Sao Paulo); 2012 Aug; 67(8):973-5. PubMed ID: 22948470
[No Abstract] [Full Text] [Related]
8. Localization and postoperative follow-up of a bronchial carcinoid tumor causing Cushing's syndrome by 111In-DTPA labelled octreotide scintigraphy.
Fernandez-Fernandez F; Halperin I; Manzanares JM; Flores L; Lomeña F; Vilardell E
J Endocrinol Invest; 1997 Jun; 20(6):327-30. PubMed ID: 9294778
[TBL] [Abstract][Full Text] [Related]
9. Localization of adrenocorticotropic hormone-secreting bronchial carcinoid tumor by somatostatin-receptor scintigraphy.
Weiss M; Yellin A; Husza'r M; Eisenstein Z; Bar-Ziv J; Krausz Y
Ann Intern Med; 1994 Aug; 121(3):198-9. PubMed ID: 7912484
[No Abstract] [Full Text] [Related]
10. [Cushing's syndrome secondary to bronchial carcinoid tumor: contribution of gammagraphy with 111In-DTPA octreotide in the localization diagnosis].
Peña González E; Lampreave Márquez JL; León Atance P; Moreno Esteban B; Bittini Copano A; Folqué Gómez E
An Med Interna; 1999 Nov; 16(11):577-9. PubMed ID: 10637999
[TBL] [Abstract][Full Text] [Related]
11. Comment on primary localization of an ectopic ACTH-producing bronchial carcinoid tumor by indium111 pentetreotide scintigraphy.
Reincke M; Allolio B; Arlt W; Körber C
J Clin Endocrinol Metab; 1999 Sep; 84(9):3399-400; author reply 3402-3. PubMed ID: 10487718
[No Abstract] [Full Text] [Related]
12. Somatostatin analogs for the localization and preoperative treatment of an adrenocorticotropin-secreting bronchial carcinoid tumor.
Phlipponneau M; Nocaudie M; Epelbaum J; De Keyzer Y; Lalau JD; Marchandise X; Bertagna X
J Clin Endocrinol Metab; 1994 Jan; 78(1):20-4. PubMed ID: 7904613
[TBL] [Abstract][Full Text] [Related]
13. Mifepristone effects on tumor somatostatin receptor expression in two patients with Cushing's syndrome due to ectopic adrenocorticotropin secretion.
de Bruin C; Hofland LJ; Nieman LK; van Koetsveld PM; Waaijers AM; Sprij-Mooij DM; van Essen M; Lamberts SW; de Herder WW; Feelders RA
J Clin Endocrinol Metab; 2012 Feb; 97(2):455-62. PubMed ID: 22090282
[TBL] [Abstract][Full Text] [Related]
14. Cushing's syndrome associated with a chemodectoma and a carcinoid tumour.
Tremble JM; Buxton-Thomas M; Hopkins D; Kane P; Bailey D; Harris PE
Clin Endocrinol (Oxf); 2000 Jun; 52(6):789-93. PubMed ID: 10848885
[TBL] [Abstract][Full Text] [Related]
15. Management of occult adrenocorticotropin-secreting bronchial carcinoids: limits of endocrine testing and imaging techniques.
Loli P; Vignati F; Grossrubatscher E; Dalino P; Possa M; Zurleni F; Lomuscio G; Rossetti O; Ravini M; Vanzulli A; Bacchetta C; Galli C; Valente D
J Clin Endocrinol Metab; 2003 Mar; 88(3):1029-35. PubMed ID: 12629081
[TBL] [Abstract][Full Text] [Related]
16. Ectopic ACTH syndrome in children and adolescents.
More J; Young J; Reznik Y; Raverot G; Borson-Chazot F; Rohmer V; Baudin E; Coutant R; Tabarin A;
J Clin Endocrinol Metab; 2011 May; 96(5):1213-22. PubMed ID: 21346064
[TBL] [Abstract][Full Text] [Related]
17. Dual bronchial carcinoids and Cushing's syndrome with a paradoxical response to dexamethasone and a false positive outcome of inferior petrosal sinus sampling.
Burman P; Lethagen A; Ivancev K; Johansson L; Sundin A
Eur J Endocrinol; 2008 Oct; 159(4):483-8. PubMed ID: 18625689
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients with negative radioiodine scintigraphy.
Valli N; Catargi B; Ronci N; Leccia F; Guyot M; Roger P; Ducassou D; Tabarin A
Thyroid; 1999 Jun; 9(6):583-9. PubMed ID: 10411121
[TBL] [Abstract][Full Text] [Related]
19. Octreoscan in patients with bronchial carcinoid tumours.
Granberg D; Sundin A; Janson ET; Oberg K; Skogseid B; Westlin JE
Clin Endocrinol (Oxf); 2003 Dec; 59(6):793-9. PubMed ID: 14974924
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the somatostatin receptor subtype in a bronchial carcinoid tumor responsible for Cushing's syndrome.
Lefebvre H; Jégou S; Leroux P; Dero M; Vaudry H; Kuhn JM
J Clin Endocrinol Metab; 1995 Apr; 80(4):1423-8. PubMed ID: 7714118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
